Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.61
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
1.93
Today|||52-Week Range
7.85
-17.74%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.61
Today’s open2.61
Day’s range2.53 - 2.68
Volume22,975
Average volume (3 months)89,049
Market cap$13.4M
Dividend yield--
Data as of 3:59pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)+35.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.67

Competitors

 Today’s
change
Today’s
% change
CYANCyanotech Corp-0.10-2.38%
ATOSAtossa Genetics Inc+0.06+9.97%
BVXVBiondVax Pharmaceuti...+0.00+0.00%
ISRIsoRay Inc+0.05+9.18%
Data as of 4:02pm ET, 04/26/2017

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$2.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts


Search for Jobs